2025

Sleep-related hypermotor epilepsy in a patient with myelin-oligodendrocyte-glycoprotein antibody disease. Holm-Mercer L, Camera V, Leite MI, Adcock J, Leschziner G, Palace J, Wren DR, Messina S. BMJ Case Rep. 2025 Apr 15;18(4):e263755.

Hallucinations and related perceptual phenomena in systemic lupus erythematosus and inflammatory arthritis: a cross-sectional mixed methods study. Arunasalam A, Pollak TA, Varshney A, Bourgeois JA, D'Cruz D, Leschziner G, Pitkanen M, Bortoluzzi A, Calderwood L, Naidu K, Dunbar E, Andreoli L, Piper M, Taylor S, Sloan M.J Acad Consult Liaison Psychiatry. 2025 May 19:S2667-2960(25)00486-0.

Assessing sleep disturbance and daytime sleepiness in people with epilepsy: A United Kingdom survey of four categories of healthcare professional. Leschziner G, Bruno E, Arlandis MT.Epilepsy Behav. 2025 May 19;170:110483.

2024

Trends and variation in issuance of high-cost narcolepsy drugs by NHS England organisations and regions from 2019 to 2022. van Someren F, Wiedemann M, Warren-Gash C, Sykorova M, Mistry H, Miller MA, Leschziner G, Nolte E, Belot A, Smith IE, Quinnell T, Eriksson SH, Strongman H.J Sleep Res. 2024 Dec 8:e14415. doi: 10.1111/jsr.14415.

Neuropsychiatric prodromes and symptom timings in relation to disease onset and/or flares in SLE: results from the mixed methods international INSPIRE study. Sloan M, Bourgeois JA, Leschziner G, Pollak TA, Pitkanen M, Harwood R, Bosley M, Bortoluzzi A, Andreoli L, Diment W, Brimicombe J, Ubhi M, Barrere C, Naughton F, Gordon C, D'Cruz D.EClinicalMedicine. 2024 May 20;73:102634.

Attribution of neuropsychiatric symptoms and prioritization of evidence in the diagnosis of neuropsychiatric lupus: mixed methods analysis of patient and clinician perspectives from the international INSPIRE study. Sloan M, Andreoli L, Zandi MS, Harwood R, Pitkanen M, Sloan S, Barrere C, Massou E, Wincup C, Bosley M, Naughton F, Ubhi M, Jayne D, Leschziner G, Brimicombe J, Diment W, Middleton K, Gordon C, D'Cruz D, Pollak TA. Rheumatology (Oxford). 2024 Dec 1;63(12):3471-3485.

Detecting early signs of deterioration and preventing hospitalizations in skilled nursing facilities using remote respiratory monitoring. Lauteslager T, Dishakjian V, Watson L, Savarese J, Williams AJ, Leschziner GD.Respir Med Case Rep. 2024 May 24;50:102044.

Neuropsychiatric symptoms in Systemic Lupus Erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE project. Sloan M, Pollak TA, Massou E, Leschziner G, Andreoli L, Harwood R, Bosley M, Pitkanen M, Diment W, Bortoluzzi A, Zandi MS, Ubhi M, Gordon C, Jayne D, Naughton F, Barrere C, Wincup C, Brimicombe J, Bourgeois JA, D'Cruz D. Rheumatology (Oxford). 2024 Mar 22:keae194. doi: 10.1093/rheumatology/keae194.

The Motor Dysfunction Seen in Isolated REM Sleep Behavior Disorder. Simonet C, Pérez-Carbonell L, Galmés-Ordinas MA, Huxford BFR, Chohan H, Gill A, Leschziner G, Lees AJ, Schrag A, Noyce AJ. Mov Disord. 2024 Mar 12. doi: 10.1002/mds.29779.

2023

Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study. Sloan M, Wincup C, Harwood R, Pollak TA, Massou E, Bosley M, Pitkanen M, Zandi MS, Leschziner G, Barrere C, Ubhi M, Andreoli L, Brimicombe J, Diment W, Jayne D, Gordon C, Naughton F, D'Cruz D. Rheumatology. 2023 Jul 26:kead369.

Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure. Pérez-Carbonell L, Simonet C, Chohan H, Gill A, Leschziner G, Schrag A, Noyce AJ. Mov Disord. 2023 Apr 12. doi: 10.1002/mds.29403.

The effect of a change from face-to-face to remote positive airway pressure education for patients with sleep apnoea during the coronavirus disease-2019 pandemic: a prospective cohort study.Meurling IJ, Birdseye A, Gell R, Sany E, Brown R, Higgins S, Muza R, O'Regan D, Leschziner G, Steier J, Rosenzweig I, Drakatos P.J Thorac Dis. 2023 Feb 28;15(2):820-828. doi: 10.21037/jtd-22-1816.

Impairment in REM-sleep behaviour disorder and individuals at risk of Parkinson's disease. Nagy AV, Leschziner G, Eriksson SH, Lees A, Noyce AJ, Schrag A. Parkinsonism & Related Disorders 2023, April, 105312.

Group Cognitive Behavioural Therapy for Non-Rapid Eye Movement Parasomnias: Long-Term Outcomes and Impact of Covid-19 Lockdown. Laroche M, Biabani N, Drakatos P, Selsick H, Leschziner G, Steier J, Young AH, Eriksson S, Nesbitt A, Kumari V, Rosenzweig I, O’Regan D. Brain Sci 2023, 13(2), 347.

Non-REM parasomnias: a scoping review of dreams and dreamlike mentation. Longe O, Omodan A, Leschziner G, Rosenzweig I. Croat Med J. 2022 Dec 31;63(6):525-535. doi: 10.3325/cmj.2022.63.525.

2022

What respiratory physicians should know about parasomnias. Meurling IJ, Leschziner G, Drakatos P. Breathe (Sheff). 2022 Sep;18(3):220067. doi: 10.1183/20734735.0067-2022.

Nocturnal visual hallucinations in patients with disorders of arousal: a novel behavioral and EEG pattern. Gnoni V, Duncan I, Wasserman D, Higgins S, Drakatos P, Birdseye A, Pérez-Carbonell L, Nesbitt A, Koutroumanidis M, Leschziner G, Rosenzweig I. Croat Med J. 2022 Oct 31;63(5):438-447.

Understanding and approaching excessive daytime sleepiness. Pérez-Carbonell L, Mignot E, Leschziner G, Dauvilliers Y. Lancet. 2022 Sep 24;400(10357):1033-1046.

Sleep quality, stress level and COVID-19 in university students; the forgotten dimension. Dongol E, Shaker K, Abbas A, Assar A, Abdelraoof M, Saady E, Hassan A, Youssef O, Essam M, Mahmoud M, Leschziner G. Sleep Sci. 2022 Apr-Jun;15(Spec 2):347-354.

Prevalence and utility of overnight pulse oximetry as a screening tool for obstructive sleep apnoea in newly diagnosed idiopathic intracranial hypertension. Kok LT, Gnoni V, Muza R, Nesbitt A, Leschziner G, Wong SH. Eye (Lond). 2022 Feb 24:1-6.

2021

Evaluation of absences and myoclonic seizures in adults with genetic (idiopathic) generalized epilepsy: a comparison between self-evaluation and objective evaluation based on home video-EEG telemetry. Elmali AD, Begley K, Chester H, Cooper J, Moreira C, Sharma S, Whelan A, Leschziner G, Richardson MP, Stern W, Koutroumanidis M. Epileptic Disord. 2021 Oct 1;23(5):719-732.

A Novel Group Cognitive Behavioral Therapy Approach to Adult Non-rapid Eye Movement Parasomnias. O'Regan D, Nesbitt A, Biabani N, Drakatos P, Selsick H, Leschziner GD, Steier J, Birdseye A, Duncan I, Higgins S, Kumari V, Stokes PR, Young AH, Rosenzweig I. Front Psychiatry. 2021 Jul 1;12:679272.

Validation of a New Contactless and Continuous Respiratory Rate Monitoring Device Based on Ultra-Wideband Radar Technology. Lauteslager T, Maslik M, Siddiqui F, Marfani S, Leschziner GD, Williams AJ. Sensors (Basel). 2021 Jun 11;21(12):4027.

Cyclic alternating pattern in obstructive sleep apnea: A preliminary study. Gnoni V, Drakatos P, Higgins S, Duncan I, Wasserman D, Kabiljo R, Mutti C, Halasz P, Goadsby PJ, Leschziner GD, Rosenzweig I. J Sleep Res. 2021 Dec;30(6):e13350.

Kleine-Levin syndrome is associated with birth difficulties and genetic variants in the TRANK1 gene loci. Ambati A, Hillary R, Leu-Semenescu S, Ollila HM, Lin L, During EH, Farber N, Rico TJ, Faraco J, Leary E, Goldstein-Piekarski AN, Huang YS, Han F, Sivan Y, Lecendreux M, Dodet P, Honda M, Gadoth N, Nevsimalova S, Pizza F, Kanbayashi T, Peraita-Adrados R, Leschziner GD, Hasan R, Canellas F, Kume K, Daniilidou M, Bourgin P, Rye D, Vicario JL, Hogl B, Hong SC, Plazzi G, Mayer G, Landtblom AM, Dauvilliers Y, Arnulf I, Mignot EJ. Proc Natl Acad Sci U S A. 2021 Mar 23;118(12):e2005753118.

Shift work is associated with increased risk of COVID-19: Findings from the UK Biobank cohort. Fatima Y, Bucks RS, Mamun AA, Skinner I, Rosenzweig I, Leschziner G, Skinner TC. J Sleep Res. 2021 Oct;30(5):e13326.

Striatal Dopaminergic Deficit and Sleep in Idiopathic Rapid Eye Movement Behaviour Disorder: An Explorative Study. Wasserman D, Bindman D, Nesbitt AD, Cash D, Milosevic M, Francis PT, Chaudhuri KR, Leschziner GD, Ferini-Strambi L, Ballard C, Eccles A, Rosenzweig I. Nat Sci Sleep. 2021 Jan 6;13:1-9.

2020

Impact of the novel coronavirus (COVID-19) pandemic on sleep. Pérez-Carbonell L, Meurling IJ, Wassermann D, Gnoni V, Leschziner G, Weighall A, Ellis J, Durrant S, Hare A, Steier J. J Thorac Dis. 2020 Oct;12(Suppl 2):S163-S175.

Sleep trajectories and mediators of poor sleep: findings from the longitudinal analysis of 41,094 participants of the UK Biobank cohort. Fatima Y, Bucks RS, Mamun AA, Skinner I, Rosenzweig I, Leschziner G, Skinner TC. Sleep Med. 2020 Dec;76:120-127.

The innate immune toll-like-receptor-2 modulates the depressogenic and anorexiolytic neuroinflammatory response in obstructive sleep apnoea. Polsek D, Cash D, Veronese M, Ilic K, Wood TC, Milosevic M, Kalanj-Bognar S, Morrell MJ, Williams SCR, Gajovic S, Leschziner GD, Mitrecic D, Rosenzweig I. Sci Rep. 2020 Jul 10;10(1):11475.

The subcortical belly of sleep: New possibilities in neuromodulation of basal ganglia? Hasegawa H, Selway R, Gnoni V, Beniczky S, Williams SCR, Kryger M, Ferini-Strambi L, Goadsby P, Leschziner GD, Ashkan K, Rosenzweig I. Sleep Med Rev. 2020 Aug;52:101317.

Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. Goldstein LH, Robinson EJ, Mellers JDC, Stone J, Carson A, Reuber M, Medford N, McCrone P, Murray J, Richardson MP, Pilecka I, Eastwood C, Moore M, Mosweu I, Perdue I, Landau S, Chalder T; CODES study group. Lancet Psychiatry. 2020 Jun;7(6):491-505.

Co-activation of rhythms during alpha band oscillations as an interictal biomarker of exploding head syndrome. Fotis Sakellariou D, Nesbitt AD, Higgins S, Beniczky S, Rosenzweig J, Drakatos P, Gildeh N, Murphy PB, Kent B, Williams AJ, Kryger M, Goadsby PJ, Leschziner GD, Rosenzweig I. Cephalalgia. 2020 Aug;40(9):949-958.

Adherence to wakefulness promoting medication in patients with narcolepsy. Pérez-Carbonell L, Lyons E, Gnoni V, Higgins S, Otaiku AI, Leschziner GD, Drakatos P, d'Ancona G, Kent BD. Sleep Med. 2020 Jun;70:50-54.

Cotard parasomnia: le délire de negation that occur during the sleep-wake dissociation? Gnoni V, Higgins S, Nesbitt AD, Wasserman D, Duncan I, Birdseye A, Pérez-Carbonell L, Drakatos P, Koutramanidis M, Ferini-Strambi L, Leschziner GD, Rosenzweig I. J Clin Sleep Med. 2020 Jun 15;16(6):971-976.

[Sleep-disordered breathing as a consequence of vagus nerve stimulation]. Pérez-Carbonell L, Higgins S, Koutroumanidis M, Leschziner G. Rev Neurol. 2020 Mar 1;70(5):179-182.

Vagus nerve stimulation for drug-resistant epilepsy. Pérez-Carbonell L, Faulkner H, Higgins S, Koutroumanidis M, Leschziner G. Pract Neurol. 2020 May;20(3):189-198.

2019

Characteristics of 698 patients with dissociative seizures: A UK multicenter study. Goldstein LH, Robinson EJ, Reuber M, Chalder T, Callaghan H, Eastwood C, Landau S, McCrone P, Medford N, Mellers JDC, Moore M, Mosweu I, Murray J, Perdue I, Pilecka I, Richardson MP, Carson A, Stone J; CODES Study Group. Epilepsia. 2019 Nov;60(11):2182-2193.

Glycine receptor autoantibodies disrupt inhibitory neurotransmission. Crisp SJ, Dixon CL, Jacobson L, Chabrol E, Irani SR, Leite MI, Leschziner G, Slaght SJ, Vincent A, Kullmann DM. Brain. 2019 Nov 1;142(11):3398-3410.

Diagnosis and management of nonrapid eye movement-parasomnias. Drakatos P, Leschziner G. Curr Opin Pulm Med. 2019 Nov;25(6):629-635.

Video polysomnographic findings in non-rapid eye movement parasomnia. Drakatos P, Marples L, Muza R, Higgins S, Nesbitt A, Dongol EM, Macavei R, Gnoni V, Perez Carbonell L, Duncan I, Birdseye A, Dastagir S, Rosenzweig I, O'Regan D, Williams AJ, Leschziner GD, Kent BD. J Sleep Res. 2019 Apr;28(2):e12772.

NREM parasomnias: a treatment approach based upon a retrospective case series of 512 patients. Drakatos P, Marples L, Muza R, Higgins S, Gildeh N, Macavei R, Dongol EM, Nesbitt A, Rosenzweig I, Lyons E, d'Ancona G, Steier J, Williams AJ, Kent BD, Leschziner G. Sleep Med. 2019 Jan;53:181-188.

2018

Clinical update on central hypersomnias. Pérez-Carbonell L, Leschziner G. J Thorac Dis. 2018 Jan;10(Suppl 1):S112-S123.

Obstructive sleep apnoea and Alzheimer's disease: In search of shared pathomechanisms. Polsek D, Gildeh N, Cash D, Winsky-Sommerer R, Williams SCR, Turkheimer F, Leschziner GD, Morrell MJ, Rosenzweig I. Neurosci Biobehav Rev. 2018 Mar;86:142-149.

Effectiveness and side-effect profile of stimulant therapy as monotherapy and in combination in the central hypersomnias in clinical practice. Thakrar C, Patel K, D'ancona G, Kent BD, Nesbitt A, Selsick H, Steier J, Rosenzweig I, Williams AJ, Leschziner GD, Drakatos P. J Sleep Res. 2018 Aug;27(4):e12627.

2017

Phasic activity and the importance of irregular breathing. Drakatos P, Kent BD, Birdseye A, Dastagir S, Higgins S, Williams AJ, Leschziner G. Sleep Med. 2017 Oct;38:21-23.

Safety and efficacy of long-term use of sodium oxybate for narcolepsy with cataplexy in routine clinical practice. Drakatos P, Lykouras D, D'Ancona G, Higgins S, Gildeh N, Macavei R, Rosenzweig I, Steier J, Williams AJ, Muza R, Kent BD, Leschziner G. Sleep Med. 2017 Jul;35:80-84

Functional reorganization in obstructive sleep apnoea and insomnia: A systematic review of the resting-state fMRI. Khazaie H, Veronese M, Noori K, Emamian F, Zarei M, Ashkan K, Leschziner GD, Eickhoff CR, Eickhoff SB, Morrell MJ, Osorio RS, Spiegelhalder K, Tahmasian M, Rosenzweig I. Neurosci Biobehav Rev. 2017 Jun;77:219-231.

Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire. Ferner RE, Thomas M, Mercer G, Williams V, Leschziner GD, Afridi SK, Golding JF. Health Qual Life Outcomes. 2017 Feb 14;15(1):34.

Creation of an international registry to support discovery in schwannomatosis. Ostrow KL, Bergner AL, Blakeley J, Evans DG, Ferner R, Friedman JM, Harris GJ, Jordan JT, Korf B, Langmead S, Leschziner G, Mautner V, Merker VL, Papi L, Plotkin SR, Slopis JM, Smith MJ, Stemmer-Rachamimov A, Yohay K, Belzberg AJ. Am J Med Genet A. 2017 Feb;173(2):407-413.

Catathrenia, a REM predominant disorder of arousal? Drakatos P, Higgins S, Duncan I, Stevens S, Dastagir S, Birdseye A, Lykouras D, Muza R, Gildeh N, Rosenzweig I, Williams AJ, Leschziner GD, Kent BD. Sleep Med. 2017 Apr;32:222-226.

2016

Migraine with brainstem aura presenting as recurrent hypersomnia (Kleine-Levin syndrome). Nesbitt AD, Leschziner GD. Pract Neurol. 2016 Oct;16(5):402-5.

Changes in Neurocognitive Architecture in Patients with Obstructive Sleep Apnea Treated with Continuous Positive Airway Pressure. Rosenzweig I, Glasser M, Crum WR, Kempton MJ, Milosevic M, McMillan A, Leschziner GD, Kumari V, Goadsby P, Simonds AK, Williams SC, Morrell MJ. EBioMedicine. 2016 May;7:221-9.

The Association Between Obstructive Sleep Apnea and Alzheimer's Disease: A Meta-Analysis Perspective. Emamian F, Khazaie H, Tahmasian M, Leschziner GD, Morrell MJ, Hsiung GY, Rosenzweig I, Sepehry AA. Front Aging Neurosci. 2016 Apr 12;8:78.

The utility of respiratory inductance plethysmography in REM sleep scoring during multiple sleep latency testing. Drakatos P, Higgins S, Duncan I, Bridle K, Briscoe S, Leschziner GD, Kent BD, Williams AJ. Respir Physiol Neurobiol. 2016 Aug;230:1-4.

Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England. Stowe J, Andrews N, Kosky C, Dennis G, Eriksson S, Hall A, Leschziner G, Reading P, Shneerson JM, Donegan K, Miller E. Sleep. 2016 May 1;39(5):1051-7.

Cataplexy with Normal Sleep Studies and Normal CSF Hypocretin: An Explanation? Drakatos P, Leschziner G. J Clin Sleep Med. 2016 Mar;12(3):449-50.

Sleep-stage sequencing of sleep-onset REM periods in MSLT predicts treatment response in patients with narcolepsy. Drakatos P, Patel K, Thakrar C, Williams AJ, Kent BD, Leschziner GD. J Sleep Res. 2016 Apr;25(2):203-10.

Derived Arterial Stiffness is Increased in Patients with Obstructive Sleep Apnea and Periodic Limb Movements during Sleep. Drakatos P, Higgins S, Pengo MF, Kent BD, Muza R, Karkoulias K, Leschziner G, Williams A. J Clin Sleep Med. 2016 Feb;12(2):195-202.

2015

Characterisation of sleep disturbances in postural orthostatic tachycardia syndrome: a polysomnography-based study. Pengo MF, Higgins S, Drakatos P, Martin K, Gall N, Rossi GP, Leschziner G. Sleep Med. 2015 Dec;16(12):1457-61.

Focal inhibitory seizures: a cause of recurrent transient weakness. Chowdhury FA, Connor S, Ferner R, Leschziner G. Pract Neurol. 2015 Dec;15(6):460-2.

Bed Partner "Gas-Lighting" as a Cause of Fictitious Sleep-Talking. Bashford J, Leschziner G. J Clin Sleep Med. 2015 Oct 15;11(10):1237-8.

Prevalence and clinical presentation of headache in a National Neurofibromatosis 1 Service and impact on quality of life. Afridi SK, Leschziner GD, Ferner RE. Am J Med Genet A. 2015 Oct;167A(10):2282-5.

Sleep apnoea and the brain: a complex relationship. Rosenzweig I, Glasser M, Polsek D, Leschziner GD, Williams SC, Morrell MJ. Lancet Respir Med. 2015 May;3(5):404-14.

2014

Update on hypersomnias of central origin. Drakatos P, Leschziner GD. Curr Opin Pulm Med. 2014 Nov;20(6):572-80.

Headache, drugs and sleep. Nesbitt AD, Leschziner GD, Peatfield RC. Cephalalgia. 2014 Sep;34(10):756-66.

Narcolepsy: a clinical review. Leschziner G. Pract Neurol. 2014 Oct;14(5):323-31.

2013

Insular seizures causing sleep-related breathlessness. Nesbitt AD, Kosky CA, Leschziner GD. Lancet. 2013 Nov 23;382(9906):1756.

First rapid eye movement sleep periods and sleep-onset rapid eye movement periods in sleep-stage sequencing of hypersomnias. Drakatos P, Kosky CA, Higgins SE, Muza RT, Williams AJ, Leschziner GD. Sleep Med. 2013 Sep;14(9):897-901.

Sleep disturbance as part of the neurofibromatosis type 1 phenotype in adults. Leschziner GD, Golding JF, Ferner RE.Am J Med Genet A. 2013 Jun;161A(6):1319-22.

2012

The NFTI-QOL: A Disease-Specific Quality of Life Questionnaire for Neurofibromatosis 2. Hornigold RE, Golding JF, Leschziner G, Obholzer R, Gleeson MJ, Thomas N, Walsh D, Saeed S, Ferner RE. J Neurol Surg B Skull Base. 2012 Apr;73(2):104-11.

Sleep stage sequence analysis of sleep onset REM periods in the hypersomnias. Drakatos P, Suri A, Higgins SE, Ebrahim IO, Muza RT, Kosky CA, Williams AJ, Leschziner GD. J Neurol Neurosurg Psychiatry. 2013 Feb;84(2):223-7.

Restless legs syndrome. Leschziner G, Gringras P. BMJ. 2012 May 23;344:e3056.

Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis. Smith MJ, Wallace AJ, Bowers NL, Rustad CF, Woods CG, Leschziner GD, Ferner RE, Evans DG. Neurogenetics. 2012 May;13(2):141-5.

A restless night's sleep. Athauda D, Leschziner G. BMJ. 2012 Jan 9;344:d8347.

An unusual case of hearing loss in a patient with neurofibromatosis type 1. Leschziner G, Connor S, Wroe SJ, Ferner RE. Clin Neurol Neurosurg. 2012 Jul;114(6):735-7.

2011

Q8IYL2 is a candidate gene for the familial epilepsy syndrome of Partial Epilepsy with Pericentral Spikes (PEPS). Leschziner GD, Coffey AJ, Andrew T, Gregorio SP, Dias-Neto E, Calafato M, Bentley DR, Kinton L, Sander JW, Johnson MR. Epilepsy Res. 2011 Sep;96(1-2):109-15

Lymphomatosis cerebri presenting as a rapidly progressive dementia with a high methylmalonic acid. Leschziner G, Rudge P, Lucas S, Andrews T. J Neurol. 2011 Aug;258(8):1489-93.

Pre-2011

Amyotrophic lateral sclerosis and ocular flutter. Balaratnam MS, Leschziner GD, Seemungal BM, Bronstein AM, Guiloff RJ. Amyotroph Lateral Scler. 2010 May 3;11(3):331-4.

Nineteen-year follow-up of Waldenström's-associated neuropathy and Bing-Neel syndrome. Leschziner GD, Roncaroli F, Moss J, Guiloff RJ. Muscle Nerve. 2009 Jan;39(1):95-100.

The association between polymorphisms in RLIP76 and drug response in epilepsy. Leschziner GD, Jorgensen AL, Andrew T, Williamson PR, Marson AG, Coffey AJ, Middleditch C, Balding DJ, Rogers J, Bentley DR, Chadwick D, Johnson MR, Pirmohamed M. Pharmacogenomics. 2007 Dec;8(12):1715-22.

Common ABCB1 polymorphisms are not associated with multidrug resistance in epilepsy using a gene-wide tagging approach. Leschziner GD, Andrew T, Leach JP, Chadwick D, Coffey AJ, Balding DJ, Bentley DR, Pirmohamed M, Johnson MR. Pharmacogenet Genomics. 2007 Mar;17(3):217-20.

ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research. Leschziner GD, Andrew T, Pirmohamed M, Johnson MR. Pharmacogenomics J. 2007 Jun;7(3):154-79.

Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study. Leschziner G, Jorgensen AL, Andrew T, Pirmohamed M, Williamson PR, Marson AG, Coffey AJ, Middleditch C, Rogers J, Bentley DR, Chadwick DW, Balding DJ, Johnson MR. Lancet Neurol. 2006 Aug;5(8):668-76.

Exon sequencing and high resolution haplotype analysis of ABC transporter genes implicated in drug resistance. Leschziner G, Zabaneh D, Pirmohamed M, Owen A, Rogers J, Coffey AJ, Balding DJ, Bentley DB, Johnson MR. Pharmacogenet Genomics. 2006 Jun;16(6):439-50.

Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Chan D, Fox NC, Scahill RI, Crum WR, Whitwell JL, Leschziner G, Rossor AM, Stevens JM, Cipolotti L, Rossor MN. Ann Neurol. 2001 Apr;49(4):433-42.

Local learning of inverse kinematics in human reaching movement. P Haggard, G Leschziner, RC Miall, JF Stein. Human Movement Science, 1997; 16: 133-47.

BOOK CHAPTERS

• Neurology Section Editor, Principles and Practice of Sleep Medicine, 7th Edition. Eds Kryger, Rothm Goldstein, Dement, Elsevier, 2021

• Postural Tachycardia Syndrome and Sleep. G Leschziner. In, Postural Tachycardia Syndrome, pp. 103-107, eds. N Gall, L Kavi, MD Lobo. Springer, 2020.

• Neuropsychiatry and sleep disorders. G Leschziner, I Rosenzweig, B Kent. Oxford Textbook of Neuropsychiatry, eds. M Bodani, R Faruqui, N Agrawal (OUP, 2020).

• Restless Legs Syndrome. G Leschziner. Sleep Disorders in Psychiatric Patients. Ed: H Selsick, Springer, 2018.

• Neurology. G Christofi, G Leschziner, RS Howard. Oxford Pocketbook for PACES. Ed: R Bessant. Oxford University Press, 2012

• Sleep and the EEG. G Leschziner. e-Brain Project, 2012.

• Narcolepsy. G Leschziner. e-Brain Project, 2012.